TUGUZBAEVA, G.,
YUE, E.,
CHEN, X.,
HE, L.,
LI, X.,
JU, J.,
QIN, Y.,
PAVLOV, V.,
LU, Y.,
JIA, W.,
BAI, Y.,
NIU, Y.,
YANG, B (2019) -dissociating therapeutic
agent in vitro. Firstly, we found marked enrichment of αv integrin in collectively invading
LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) treatment. These facts necessitate a search for new pharmacological
agents for the CHF correction. Herbal
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) Arsenic trioxide (ATO) has been well recognized as an anti-tumor
agent for various human cancers